All of these MetS-induced aortic structural and cellular phenotypic changes (which may be partly due to increased activation of upregulated RAGE in aortic VSMCs) can be completely reverted by oral cotreatment with MET, probably via AMPK activation. This evidence concerns the gene AGER and metabolic syndrome.